mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |